ライフサイエンスコーパス: mannitol

1 via osmotic agents albumin, dextran 70, and mannitol.

2 ar discrimination of different polymorphs of mannitol.

3 of bioactives such as phenolic compounds and mannitol.

4 ae strain to efficiently metabolize DEHU and mannitol.

5 f alpha, beta, delta, and amorphous forms of mannitol.

6 salicylic acid treatment and challenges with mannitol.

7 on, relative hypothermia and possibly use of mannitol.

8 fectively increased by induction with 600 mM mannitol.

9 A synthesis, prevented stromule induction by mannitol.

10 ic saline, and 40% (2,500 of 6,238) received mannitol.

11 ions schedule for both hypertonic saline and mannitol.

12 et aggregation could be mimicked by infusing mannitol.

13 essed during growth on all sugars other than mannitol.

14 ), with both favoring hypertonic saline over mannitol.

15 (14)C]Suc and (14)CO(2), but not from [(14)C]mannitol.

16 catalyze the uptake and phosphorylation of d-mannitol.

17 are amplified with intravenous injection of mannitol.

18 d by intrathecal co-infusion of hyperosmolar mannitol.

19 neurons are responsive to hypertonic NaCl or mannitol.

20 ase in discharge frequency than equi-osmotic mannitol.

21 ter discharge response to hypertonic NaCl vs mannitol.

22 while 2.16-fold FPF value of the non-porous mannitol.

23 ed by auxin, but did not respond to salt and mannitol.

24 ths, all interventions reduced lactulose and mannitol (-0.60 to -0.69 log mmol/L).

25 (traumatic brain injury-saline group) or 20% mannitol (1 g/kg) (traumatic brain injury-mannitol group

26 )F]FDF), 1-deoxy-1-[(18)F]fluoro-2,5-anhydro-mannitol (1-[(18)F]FDAM), 2-deoxy-2-[(18)F]fluoro-d-gluc

27 n PBS; and group 4, intravenous injection of mannitol (1.5 g/kg) in PBS followed by intraarterial inj

28 25 mmol/L d-glucose, but not to iso-osmolar mannitol, 1) reduced the ability of L-ASA to inhibit pla

29 charge to both hypertonic NaCl (+7.5 mm) and mannitol (+15 mm).

30 permeability markers [ionic conductance (G), mannitol, 182 Da; horseradish peroxidase, 40 kDa] and gl

31 The active site of mannitol 2-dehydrogenase from Pseudomonas fluorescens (P

32 The administration of mannitol 24h after BCM-PTX injection further improved th

33 100 mm Hg and heart rate <100 beats/min plus mannitol (250 mg/kg) for intracranial hypertension.

34 significantly faster than those treated with mannitol 30 min or more before clamping the renal artery

35 ind, randomized, controlled trial of inhaled mannitol, 400 mg twice a day (n = 192, "treated" group)

36 Inhaled mannitol, 400 mg twice a day, resulted in improved lung

37 sorbide derivative (1,4:2,5:3,6-trianhydro-d-mannitol, 5).

38 ntracranial hypertension-directed therapies (mannitol, 56% vs 21%; hypertonic saline, 14% vs 7%; hypo

39 rose -6.92, dimethylsulphoxide (DMSO) -9.72, mannitol -6.69, trehalose -10.6, NaCl -11.0, glycine -14

40 on of 14 compounds: proline, phloroglucinol, mannitol, 8 fatty acids and 3 sterols.

41 e analyzed after challenge with hyperosmolar mannitol (850 mOsm).

42 deoxy-3-O-alpha-d-glucopyranosyl-2,5-imino-d-mannitol (9) to act as an inhibitor of GlgE.

43 Treatment with mannitol, a first-line edema treatment in clinical pract

44 xalate simultaneously with the flux of [(3)H]mannitol, a marker of the paracellular pathway, across i

45 siveness to acidic pH and cis-diols (such as mannitol, a safe FDA approved drug for diuresis) through

46 Our biosensor consists of Agrobacterium mannitol (ABM) agar medium, X-gal, and a biosensor.

47 cal resistance, an increase in the efflux of mannitol across the monolayer, and a loss of intracellul

48 f resulting average pore sizes showed that D-mannitol addition resulted in larger average pore size (

49 Mannitol additions were used to simulate a productivity

50 Specifically, we reduced the time of mannitol administration from 30 to 15 min or less before

51 terial PCO2, change in sevoflurane dose, and mannitol administration had no significant effect on int

52 T revealed that this change in the timing of mannitol administration protected the human donor proxim

53 Treatment with mannitol after traumatic brain injury reversed all these

54 ine (PBS); group 2, intravenous injection of mannitol alone in PBS (1.5 g/kg); group 3, intraarterial

55 Two polymorphs of D-mannitol, alpha and delta, when grown in the presence of

56 Infusion of mannitol also resulted in a greater increase in tissue N

57 y to use renal protective strategies such as mannitol and cold renal perfusion (both P < 0.01).

58 tly higher AUC0-8h value than the non-porous mannitol and commercial product Pulmicort.

59 this platform was further adapted to grow on mannitol and DEHU under anaerobic conditions, it was cap

60 it was capable of ethanol fermentation from mannitol and DEHU, achieving titres of 4.6% (v/v) (36.2

61 obtained, and airway hyperresponsiveness to mannitol and fraction of exhaled nitric oxide values wer

62 Conversion of photoassimilate into mannitol and glycerol for carbon sequestration and osmol

63 The results underline that mannitol and ionic conductance G cannot be considered ma

64 al perfusion pressure was not restored until mannitol and pressor therapy were initiated at 120 mins.

65 ion, we determined the kinetic parameters of mannitol and sorbitol dehydrogenases encoded in the yeas

66 nome, showing that they discriminate between mannitol and sorbitol to a much higher degree than the t

67 xt17 transport two major hexitols in nature, mannitol and sorbitol, with moderate affinities, by a fa

68 er SB permeability (based on 0-2 h levels of mannitol and the lactulose:mannitol ratio); SB permeabil

69 rbia, intravenous pentobarbital, intravenous mannitol and vasopressor titration for maintenance of ce

70 R,R)-hexa-1,5-diene-3,4-diol (derived from D-mannitol) and its enantiomer (derived from l-(+)-tartrat

71 ogen peroxide (catalase), hydroxyl radicals (mannitol) and singlet oxygen (sodium azide) and carbon-c

72 ermeability (alpha-1-antitrypsin, lactulose, mannitol), and repair (regenerating gene 1beta) at media

73 paration solutions (NaCl 0.9%, glycerol 12%, mannitol), and two biopsy forceps (standard and jumbo) i

74 choline responders (n = 74) were negative to mannitol, and 16% of mannitol responders (n = 76) were n

75 We found that trehalose, mannitol, and arabitol were the main soluble sugars in t

76 Sorbitol, mannitol, and galactitol were converted via 1,6-tritylat

77 abundant sugars in macroalgae are alginate, mannitol, and glucan, and although several classes of en

78 5-hydroxymethylfurfural, xylitol, sorbitol, mannitol, and gluconic acid as biorefinery platform chem

79 of three additional PTS sugars: cellobiose, mannitol, and N-acetyl-D-galactosamine.

80 ce, secretory flux of oxalate was similar to mannitol, and no net flux of oxalate occurred.

81 nanoparticles and a hyperosmolar solution of mannitol, and pre-infusion of an isotonic buffer solutio

82 bacteria and yeasts to overproduce xylitol, mannitol, and sorbitol.

83 D-glucose, D-fructose, saccharin, D-mannitol, and water were infused for 3 hours, before har

84 Both hypertonic saline and mannitol appear to lower intracranial pressure and impro

85 del in which, when carbon sources other than mannitol are present, MtlS sRNA is transcribed, base pai

86 Hypertonic saline and mannitol are used less in infants than in older children

87 We therefore suggest mannitol as a basis for a dual mechanism therapeutic age

88 al barrier breakdown was assessed using (3)H-mannitol as a tracer.

89 suggest that care should be taken when using mannitol as an osmoticum.

90 Ac, 7 mg/kg) to inhibit O-GlcNAc removal, or mannitol as control.

91 ls were treated with high glucose (30 mm) or mannitol as osmotic control.

92 rmulations of TMC with a suitable excipient (mannitol) as inhalable particles with tailored particle

93 [Malus domestica]), and one that transports mannitol (Asarina scandens).

94 Among these samples, mannitol based proniosome powder (MAPP) produced small v

95 BBB opening with mannitol before intraarterial infusion of (89)Zr-BVDFO r

96 D-Mannitol belongs to a large and growing family of crysta

97 cholate (CCFA-HT), and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme (CCMB-TAL)

98 sociated with airway eosinophilia and AHR to mannitol but not airway neutrophilia.

99 he reaction can be mimicked by inhalation of mannitol, but it has paradoxically previously not been p

100 indicate that an antiedematous agent such as mannitol can improve brain tissue oxygenation, possibly

101 extensive re-engineering of the alginate and mannitol catabolic pathways in the standard industrial m

102 ry bacterial alginate and deregulated native mannitol catabolism genes, conferred the ability of an S

103 Ten minutes of exposure to mannitol caused a small initial contraction (12% +/- 1%

104 a positive methacholine (PC20 < 8 mg/mL) or mannitol challenge (PD15 < 635 mg), and 30% were non-res

105 th dry air was conducted in 42 players and a mannitol challenge in 18 players.

106 re carried out: spirometry, methacholine and mannitol challenge, exhaled nitric oxide (FeNO); Asthma

107 role of direct (methacholine) and indirect (mannitol) challenge testing in community managed asthma.

108 In random order, methacholine or mannitol challenges were performed 24 h pre- and post-al

109 patterns were observed for compounds such as mannitol, citrate, and alpha-hydroxyisobutyrate and conf

110 nsient, hyperemic response to IC infusion of mannitol compared to normal saline.

111 at formation of the productive enzyme-NAD(+)-mannitol complex is promoted by a corresponding position

112 immediately preceding catalytic oxidation of mannitol, consistent with the notion that formation of t

113 gh molecular weight auxiliary excipients and mannitol containing formulations were unstable and cryst

114 Mannitol content in freeze-dried U. pinnatifida was also

115 Findings also revealed that the highest mannitol content in the extracts was observed with the c

116 We compared mannitol content, sensory quality and volatile profiles

117 In this study, D-mannitol crystals were mixed with photocrosslinkable met

118 D-mannitol crystals were observed to dissolve and leave th

119 deoxy-3-O-alpha-D-glucopyranosyl-2,5-imino-D-mannitol (DDGIM), an oxocarbenium mimic, was solved to 2

120 ased in a high C/N ratio, while fructose and mannitol decreased.

121 ble bioorthogonal chemistries, we conjugated mannitol dehydrogenase to formate dehydrogenase with the

122 itol, coexpression of formate dehydrogenase, mannitol dehydrogenase, and a glucose facilitator protei

123 , we show that relocalization in response to mannitol depends on QSK1 phosphorylation.

124 ct (-)-gracilioether F is described from a d-mannitol derived known compound.

125 d olefinic amides that uses a C(2)-symmetric mannitol-derived cyclic selenium catalyst and a stoichio

126 s between d-arabinose-derived nitrones and d-mannitol-derived trans-olefins have been utilized to syn

127 with carboxymethylcellulose (CMC), although mannitol did not form our micro-structures so was discou

128 The solution properties of d-Mannitol (DM) were studied to explore sweetness response

129 dministered to a Parkinson Drosophila model, mannitol dramatically corrected its behavioral defects a

130 ICA infusions of hypertonic NaCl and mannitol each significantly (P < 0.01-0.001) increased t

131 Mannitol enabled the complex to be lyophilized to yield

132 (e.g., lactulose) and sugar alcohols (e.g., mannitol), establishing a differential probe.

133 nsit, mucosal permeability (by lactulose and mannitol excretion), and cytokine production by peripher

134 pharmacokinetic studies since the nanoporous mannitol exhibited a significantly higher AUC0-8h value

135 n acidic pH environment or by administrating mannitol, facilitating drug release in an acidic tumor e

136 n depletion by local perfusion with isotonic mannitol failed to reduce the gating charge further.

137 analyzed pHis peptides from glycerol-fed and mannitol-fed Escherichia coli cells.

138 opy, informs the cooperative organization of mannitol fibers.

139 4 patients who received hypertonic saline or mannitol for >/= 2 days in the first week of therapy, 29

140 ervations included the following: dry powder mannitol for inhalation as a bronchial provocation test

141 ined systolic blood pressure >100 mm Hg plus mannitol for intracranial hypertension.

142 dical relevance such as sugars lactulose and mannitol for noninvasive gut permeability assessment.

143 pertonic saline solutions may be superior to mannitol for the treatment of elevated intracranial pres

144 olar doses of hypertonic sodium solutions to mannitol for the treatment of elevated intracranial pres

145 hat hypertonic saline is more effective than mannitol for the treatment of elevated intracranial pres

146 Results indicated that crystalline mannitol fractured at the hydrophilic (011) plane, as ob

147 rategy to overcome the current limitation of mannitol fragmentation and provide improvements in table

148 for germination, and carbon sources such as mannitol, fructose, sorbitol, raffinose and stachyose fo

149 challenge decreased airway responsiveness to mannitol; geometric mean (95% CI) dose-response ratio wa

150 0% mannitol (1 g/kg) (traumatic brain injury-mannitol group).

151 Sham-saline and sham-mannitol groups received no insult.

152 In the absence of traumatic brain injury, mannitol had no effect on brain oxygenation.

153 It appears that mannitol has a general neuroprotective effect in the tra

154 eterioration as well as the effects of salt, mannitol, heat, cold, and abscisic acid (ABA) with and w

155 andard cooling rate induced the formation of mannitol hemihydrate, and a secondary drying temperature

156 e protocol for intravenous administration of mannitol (i.e., 12.5 or 25 g) to the donor.

157 to the differentiation between origins, with mannitol identified as an important discriminating metab

158 present study, we tested the hypothesis that mannitol improves the efficiency of intraarterial MSC de

159 possible to replicate this mode of action of mannitol in isolated airways.

160 fusion of equal volumes of normal saline and mannitol in our rabbit IC drug delivery model.

161 in ZO-1 enhanced permeability to oxalate and mannitol in parallel.

162 assess the fracture behaviour of crystalline mannitol in relation to the energy input during direct c

163 Mannitol increased the release of the mast cell mediator

164 tibody from the CSF, with intrathecal 0.75 m mannitol increasing the number of perivascular profiles

165 lants had higher contents of polyphenols and mannitol indicating that agronomic application of OMW wi

166 (4)) and prostacyclin (IP) also enhanced the mannitol-induced bronchoconstriction (E(max), 67% +/- 5%

167 ntrations of NaCl, KCl, and LiCl and also to mannitol-induced osmotic stress.

168 Intra-arterial (IA) infusion of mannitol induces osmotic blood-brain barrier opening (OB

169 at HG treatment, but not the osmotic control mannitol, induces csGRP78 expression through an ER stres

170 lood flow and brain metabolism occur with IA mannitol infusion.

171 and metabolic response to intraarterial (IA) mannitol infusions in order to optimize the delivery of

172 Dimethylthiourea but not mannitol inhibited IL-8 induction by ESAT-6, further sup

173 Although low concentration of mannitol inhibited the formation of fibrils, high concen

174 that the volume but not the flow rate of the mannitol injection has a significant effect on the degre

175 ortex and spinal cord; prior intraperitoneal mannitol injection increased CNS gene delivery tenfold.

176 changes returned to baseline within 5min of mannitol injection.

177 ed either just before, or concurrent with IA mannitol injections.

178 e flux of oxalate in duodenum was similar to mannitol, insensitive to DIDS, and nonsaturable, indicat

179 Mannitol is a six-carbon sugar alcohol that accumulates

180 Mannitol is an essential excipient employed in orally di

181 The loss in responsiveness to mannitol is likely not explainable by a refractory state

182 agreement about whether hypertonic saline or mannitol is more effective.

183 The addition of excipients such as mannitol is optimized for both the stabilization of prot

184 wo polymorphic forms of the small molecule d-mannitol is presented.

185 pBoB, LDA statistically segregated lactulose/mannitol (L/M) ratios from 0.1 to 0.5, consistent with v

186 leven additives (trehalose, glycine betaine, mannitol, L-Arginine, potassium citrate, CuCl(2), prolin

187 We examined lactulose:mannitol (Lac:Man) permeability in obese individuals wit

188 our different carriers, namely maltodextrin, mannitol, lactose and pullulan.

189 intracranial pressure and two reported that mannitol lowered intracranial pressure.

190 tisolvent, so that formed NPs adhered to the mannitol microparticles for easy isolation and immediate

191 Interestingly, pretreatment with d-mannitol mitigated DPHP-induced effects on SV-BA length

192 treatment with different elicitors (sucrose, mannitol, NaCl, 1-aminocyclopropane-L-carboxylic acid, s

193 mannitol rather than water, suggesting that mannitol negatively regulated the postharvest strawberry

194 ith their higher contents in phloroglucinol, mannitol, oleic, arachidonic and eicosapentaenoic acids,

195 ith their higher contents in phloroglucinol, mannitol, oleic, arachidonic and eicosapentaenoic acids,

196 vitro studies, we demonstrated the effect of mannitol on alpha-synuclein aggregation.

197 equivalent) to investigate 1) the effect of mannitol on brain edema and oxygenation, using a multipa

198 gated the effects of the antiedematous agent mannitol on brain tissue oxygenation in a model of diffu

199 he cortex and caudoputamen; 2) the effect of mannitol on brain tissue PO2 and on venous oxygen satura

200 ction of Ec-MtlR with the well characterized mannitol operator/promoter region.

201 The expression of the mannitol operon is regulated by a proposed transcription

202 ulated by a proposed transcriptional factor, mannitol operon repressor (MtlR) that was first studied

203 Specifically, the mannitol operon sRNA (MtlS sRNA; previously designated t

204 quires incorporation of highly water-soluble mannitol or a similar excipient to elicit the high-effic

205 to salt stress and osmotic stress imposed by mannitol or polyethylene glycol in culture media or by w

206 Mannitol (osmolyte) synthesis did not affect exchange or

207 e hyaluronan matrix, whereas low glucose and mannitol osmotic control cultures did not.

208 thanol and added dropwise to a dispersion of mannitol particles in heptane as an antisolvent.

209 tol was admixed to MAC at 5, 10 and 20 wt% D-mannitol per total initial hydrogel weight.

210 index of paracellular diffusion of ions, and mannitol permeability.

211 rate multispanning membrane proteins such as mannitol permease or TatC, which had been considered to

212 uation and chemical analysis (organic acids, mannitol, phenolic compounds, sugars and volatile compou

213 r 7 days (n=16) or equiosmolar free water/5% mannitol (placebo; n=15).

214 um chloride, tetraethyl ammonium bromide and mannitol, plus previously published data on six other co

215 Mannitol powder was included in the antisolvent, so that

216 0%) successfully produced co-spray dried TMC:mannitol powders.

217 ifferential scanning calorimetry showed that mannitol predominantly retained the beta-polymorph; howe

218 enous injection of rSV40s, particularly with mannitol pretreatment, resulted in extensive expression

219 or protein in Corynebacterium glutamicum for mannitol production from fructose and formate, and overe

220 regions following treatment, suggesting that mannitol promotes alpha-synuclein clearance in the cell

221 e noted in the rate of positive responses to mannitol provocation or Feno measurements.

222 the 2 sexes with airway hyperresponsiveness (mannitol provocation testing) or inflammation (Feno).

223 try, fractional exhaled nitric oxide (Feno), mannitol provocation testing, and (3)He gas magnetic res

224 orage and associated with the application of mannitol rather than water, suggesting that mannitol neg

225 used test has been the urinary lactulose to mannitol ratio (L:M), which primarily assesses gut leaki

226 urinary fractional excretion of lactulose-to-mannitol ratio (LMR) at recruitment in 1420 asymptomatic

227 poridium and rotavirus, and the lactulose to mannitol ratio for intestinal permeability was determine

228 from 9 to 15 mo, and averaged the lactulose:mannitol ratio z-score (LMZ) at 9 and 15 mo.

229 n 0-2 h levels of mannitol and the lactulose:mannitol ratio); SB permeability was greater in HLA-DQ2/

230 ired gut permeability, such as the lactulose/mannitol ratio, plasma endotoxin concentrations, and ser

231 tegrity [assessed by using urinary lactulose:mannitol ratios (LMRs)].

232 ol required to reach a 15% drop in FEV1 , or mannitol reactivity, expressed as the response dose rati

233 mainly produced delta and amorphous forms of mannitol, regardless of annealing.

234 tivity, expressed as the provocative dose of mannitol required to reach a 15% drop in FEV1 , or manni

235 nitric oxide, airway hyperresponsiveness to mannitol, respiratory system mechanics using the forced

236 = 74) were negative to mannitol, and 16% of mannitol responders (n = 76) were negative to methacholi

237 The current investigation assessed mannitol responsiveness 24 h after allergen challenge.

238 We have shown mannitol responsiveness decreases 3 h after allergen inh

239 scular permeability via measurement of [(3)H]mannitol retina to lung (RLLR) and retina to renal leaka

240 The microstructure of mannitol ring-banded spherulites compares favorably to t

241 gerated conditions in saline adenine glucose mannitol (SAGM) additives have revealed the presence of

242 nth visits and cultured by direct plating to mannitol salt agar (MSA) and CHROMagar MRSA (CM) and ove

243 gar, colistin-nalidixic acid agar (CNA), and mannitol salt agar (MSA); and 25 enteric isolates grown

244 yptic soy agar with 5% sheep blood [SBA] and mannitol salt agar [MSA]).

245 GeneOhm MRSA PCR and various culture media (mannitol salt agar with cefoxitin, MRSASelect, CHROMagar

246 od agar, chocolate agar, MacConkey agar, and mannitol salt agar.

247 We found no significant difference in mannitol sensitivity, expressed as the provocative dose

248 Preadministration of mannitol significantly increases the number of hBMSCs lo

249 In addition, mannitol solid-state form ratios were semiquantitatively

250 been disrupted by exposure to a hyperosmolar mannitol solution, permitting the transluminal transport

251 No harmful effect was found with mannitol solutions.

252 Binding studies of sugar alcohols mannitol, sorbitol, erythritol, adonitol, arabitol, gala

253 hat the commonly used stress-inducing agents mannitol, sorbitol, NaCl, and hydrogen peroxide impact s

254 arterial blood pressure whereas equi-osmotic mannitol/sorbitol did not alter any variable.

255 pressor response than infusion of hypertonic mannitol/sorbitol.

256 erial blood pressure (ABP) than equi-osmotic mannitol/sorbitol.

257 lated region of the mtl operon, encoding the mannitol-specific phosphotransferase system.

258 ding site, and inhibits the synthesis of the mannitol-specific phosphotransferase system.

259 The mannitol-specific PTS catalyze the uptake and phosphoryl

260 e mutant is affected in the root response to mannitol stress.

261 protein aggregation and carbohydrates (i.e., mannitol, sucrose, and glycerin) were used as osmolytes

262 We investigated concentrations of mannitol, sucrose, trehalose and sorbitol from 1:1 to 30

263 nd aequorin, and exploiting a D-lactate- and mannitol/sucrose-based bioenergetic shunt that greatly m

264 lA protein is present only in cells grown on mannitol sugar, whereas MtlS sRNA is expressed during gr

265 wed greater inhibition when grown on NaCl or mannitol, suggesting a role in osmotic stress resistance

266 ct on bacterial survival but protection by d-mannitol suggests hydroxyl radicals are involved in the

267 almonella species but partial quenching by d-mannitol suggests radicals other than hydroxyl may be in

268 ionation, we grew wild-type and a transgenic mannitol synthesizer Arabidopsis thaliana hydroponically

269 asures of intestinal permeability (lactulose:mannitol test, plasma zonulin, and plasma lipopolysaccha

270 the cascade reaction and produces 60% more D-mannitol than the other complex with active sites direct

271 n SGLT1 compared with water or iso-osmotic D-mannitol; this effect was replicated by D-fructose or sa

272 r without prior intraperitoneal injection of mannitol to deliver transgenes to the central nervous sy

273 croMRI) in AD transgenic mice, where we used mannitol to enhance blood brain barrier (BBB) permeabili

274 Switching perfusion from mannitol to glucose (75 mM) exerted similar effects.

275 prospective, but only one directly compared mannitol to hypertonic saline.

276 Here, we examined the ability of mannitol to interfere with the aggregation process of al

277 In mannitol-treated patients, ICU length of stay was 9.5 da

278 rylation events responsive to 5 min of 0.3 m mannitol treatment were first identified using (15)N met

279 n of conditions that maintain the delicate l-mannitol triester-triol array.

280 Hypertonic saline use increased and mannitol use decreased with publication of the 2003 guid

281 billing for parenteral hypertonic saline and mannitol use, by day of service.

282 d with glucose (150, 310, and 1000 mOsm) and mannitol used as an osmotic control agent in both experi

283 GW4 grown heterotrophically with mannitol used As(III) as a supplemental energy supply as

284 ilm formation defects, as well as changes in mannitol utilization.

285 Absorptive fluxes of both oxalate and mannitol varied in parallel in different segments of sma

286 D-mannitol was admixed to MAC at 5, 10 and 20 wt% D-mannit

287 with an intact BBB or with BBB opening with mannitol was initially monitored by dynamic PET, followe

288 nealing step on the solid-state formation of mannitol was studied.

289 ida was also measured and result showed that mannitol was the only free carbohydrate in U. pinnatifid

290 n (maximum effect [E(max)], 47% +/- 5%) when mannitol was washed out.

291 flux of oxalate in duodenum exceeded that of mannitol, was sensitive to DIDS, and saturable, indicati

292 in with 5-25 mmol/L d-glucose or iso-osmolar mannitol, we evaluated the influence of a 30-min incubat

293 and the effects of additives azide ion and d-mannitol were examined to help clarify the photokilling

294 -homonojirimycin and 2,5-dideoxy-2,5-imino-d-mannitol were the major iminosugars determined.

295 pertonic conditions (by addition of 300 mOsm mannitol), which increases intracellular protein crowdin

296 Nanoporous mannitol with a mean pore size of about 6 nm exhibited 0

297 ombic and monoclinic crystal structures of d-mannitol with data acquisition times of <7 s per field o

298 nique was firstly used to prepare nanoporous mannitol with small asperities to enhance the DPI aeroso

299 cteria including Mycobacterium tuberculosis; mannitol, with selective uptake in S. aureus and E. coli

300 Mean lactulose:mannitol z-scores during the first 2 y of life were nega